The $800 Million Pill

The Truth behind the Cost of New Drugs

Nonfiction, Health & Well Being, Medical, Patient Care, Health Care Delivery, Social & Cultural Studies, Social Science, Sociology
Cover of the book The $800 Million Pill by Merrill Goozner, University of California Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Merrill Goozner ISBN: 9780520939288
Publisher: University of California Press Publication: April 22, 2004
Imprint: University of California Press Language: English
Author: Merrill Goozner
ISBN: 9780520939288
Publisher: University of California Press
Publication: April 22, 2004
Imprint: University of California Press
Language: English

Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit.

Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place.

The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Why do life-saving prescription drugs cost so much? Drug companies insist that prices reflect the millions they invest in research and development. In this gripping exposé, Merrill Goozner contends that American taxpayers are in fact footing the bill twice: once by supporting government-funded research and again by paying astronomically high prices for prescription drugs. Goozner demonstrates that almost all the important new drugs of the past quarter-century actually originated from research at taxpayer-funded universities and at the National Institutes of Health. He reports that once the innovative work is over, the pharmaceutical industry often steps in to reap the profit.

Goozner shows how drug innovation is driven by dedicated scientists intent on finding cures for diseases, not by pharmaceutical firms whose bottom line often takes precedence over the advance of medicine. A university biochemist who spent twenty years searching for a single blood protein that later became the best-selling biotech drug in the world, a government employee who discovered the causes for dozens of crippling genetic disorders, and the Department of Energy-funded research that made the Human Genome Project possible--these engrossing accounts illustrate how medical breakthroughs actually take place.

The $800 Million Pill suggests ways that the government's role in testing new medicines could be expanded to eliminate the private sector waste driving up the cost of existing drugs. Pharmaceutical firms should be compelled to refocus their human and financial resources on true medical innovation, Goozner insists. This book is essential reading for everyone concerned about the politically charged topics of drug pricing, Medicare coverage, national health care, and the role of pharmaceutical companies in developing countries.

More books from University of California Press

Cover of the book Black Elephants in the Room by Merrill Goozner
Cover of the book Reimagining Global Health by Merrill Goozner
Cover of the book 1989 by Merrill Goozner
Cover of the book Dark Green Religion by Merrill Goozner
Cover of the book Chinese Characters by Merrill Goozner
Cover of the book Frontier Figures by Merrill Goozner
Cover of the book Authentic Wine by Merrill Goozner
Cover of the book Free for All by Merrill Goozner
Cover of the book Slave Next Door by Merrill Goozner
Cover of the book Protecting Life on Earth by Merrill Goozner
Cover of the book The Left Coast by Merrill Goozner
Cover of the book The Castrato by Merrill Goozner
Cover of the book Maize for the Gods by Merrill Goozner
Cover of the book Expression and Truth by Merrill Goozner
Cover of the book Alef Is for Allah by Merrill Goozner
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy